Encompass Health Corporation (EHC) earnings
EHC earnings moved a median of -0.31% by the close. Quarterly and annual EHC reports and results, each read against the price at its own news timestamp. Back to the EHC overview →
37 measured EHC earnings events.
Where these EHC earnings landedvs 37 measured EHC earnings reactions
| Middle 50% of EHC earnings reactions | -0.93% to +0.24% |
|---|---|
| Median reaction (to close) | -0.31% |
| Measured reactions | 37 |
Point-in-time · zero look-ahead
Half of the 37 EHC earnings events with a measured close landed between -0.93% and +0.24%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Encompass Health announces date of 2026 third-quarter earnings call | Press release | -0.45% | +0.49% | |
| Form 10-Q Encompass Health Corp For: Jun 30 | SEC filing · Form 10-Q | +0.04% | +0.00% | |
| Encompass Health reports results for second quarter 2026 | Press release | -2.47% | -0.57% | |
| Encompass Health announces date of 2026 second quarter earnings call | Press release | -0.78% | -1.19% | |
| Form 10-Q Encompass Health Corp For: Mar 31 | SEC filing · Form 10-Q | -0.09% | -0.31% | |
| Encompass Health reports results for first quarter 2026 | Press release | +3.08% | +6.01% | |
| Encompass Health announces date of 2026 first-quarter earnings call | Press release | +0.83% | +0.62% | |
| Form 10-K Encompass Health Corp For: Dec 31 | SEC filing · Form 10-K | -0.05% | -0.74% | |
| Encompass Health reports results for fourth quarter 2025 and issues 2026 guidance | Press release | -2.10% | -5.63% | |
| Encompass Health announces date of 2025 fourth quarter earnings call | Press release | -0.15% | -2.33% | |
| Form 10-Q Encompass Health Corp For: Sep 30 | SEC filing · Form 10-Q | +0.15% | -0.82% | |
| Encompass Health reports results for third quarter 2025 | Press release | +5.11% | +3.21% | |
| Encompass Health announces date of 2025 third quarter earnings call | Press release | -0.17% | -0.81% | |
| Form 10-Q Encompass Health Corp For: Jun 30 | SEC filing · Form 10-Q | +0.50% | -0.18% | |
| Encompass Health reports results for second quarter 2025 | Press release | +3.80% | +2.09% | |
| Encompass Health announces date of 2025 second quarter earnings call | Press release | +0.18% | +0.18% | |
| Form 10-Q Encompass Health Corp For: Mar 31 | SEC filing · Form 10-Q | +0.15% | -0.43% | |
| Encompass Health reports results for first quarter 2025 | Press release | -1.39% | +2.05% | |
| Encompass Health announces change in the time of 2025 first quarter earnings call | Press release | +0.14% | -0.32% | |
| Encompass Health announces date of 2025 first quarter earnings call | Press release | -1.10% | -1.63% | |
| Form 10-K Encompass Health Corp For: Dec 31 | SEC filing · Form 10-K | +0.19% | +1.12% | |
| Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance | Press release | -0.70% | -2.44% | |
| Encompass Health Announces Date of 2024 Fourth Quarter Earnings Call | Press release | +0.72% | -0.86% | |
| Form 10-Q Encompass Health Corp For: Sep 30 | SEC filing · Form 10-Q | -0.04% | -0.08% | |
| Encompass Health reports results for third quarter 2024 | Press release | -1.40% | -1.44% | |
| Encompass Health Announces Date of 2024 Third Quarter Earnings Call | Press release | +0.36% | +1.60% | |
| Form 10-Q Encompass Health Corp For: Jun 30 | SEC filing · Form 10-Q | -0.92% | -0.93% | |
| Encompass Health reports results for second quarter 2024 | Press release | -2.59% | -1.70% | |
| Encompass Health announces date of 2024 second quarter earnings call | Press release | +0.05% | +0.22% | |
| Form 10-Q Encompass Health Corp For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.24% | |
| Encompass Health reports results for first quarter 2024 | Press release | -1.35% | -2.96% | |
| Encompass Health announces date of 2024 first quarter earnings call | Press release | +0.11% | -0.09% | |
| Form 10-K Encompass Health Corp For: Dec 31 | SEC filing · Form 10-K | -0.48% | -0.79% | |
| Encompass Health reports results for fourth quarter 2023 and issues 2024 guidance | Press release | +4.18% | -0.07% | |
| Encompass Health announces date of 2023 fourth quarter earnings call | Press release | -0.03% | +0.75% | |
| Form 10-Q Encompass Health Corp For: Sep 30 | SEC filing · Form 10-Q | +0.01% | -0.11% | |
| Encompass Health reports results for third quarter 2023 | Press release | -7.17% | -2.56% |
Keep exploring
More EHC: analyst actions → · SEC filings → · EHC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VistaGen Therapeutics, Inc. (VTGN) | 658 | +0.16% | 52% |
| Quanterix Corporation (QTRX) | 657 | -0.21% | 46% |
| DIPLOMAT PHARMACY INC (DPLO) | 654 | 0.00% | 50% |
| Opiant Pharmaceuticals, Inc. (OPNT) | 654 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.